Abstract 1384: CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, reverses the HIF-1α-mediated increase in cancer stem cells caused by bevacizumab in a preclinical model of triple-negative breast cancer

2015 ◽  
Author(s):  
Sarah J. Conley ◽  
Trenton L. Baker ◽  
Joseph P. Burnet ◽  
Rebecca L. Thiesen ◽  
Douglas Lazarus ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Preclinical Model ◽  
Drug Conjugate

scholarly journals Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer

2018 ◽  
Vol 78 (8) ◽  
pp. 2052-2064 ◽  
Author(s):  
Ding Ren ◽  
Xiaoping Zhu ◽  
Ren Kong ◽  
Zhen Zhao ◽  
Jianting Sheng ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Metastatic Colonization

Abstract 4076: Combination of docetaxel with sulforaphane synergistically inhibits triple negative breast cancer and cancer stem cells

2015 ◽  
Author(s):  
Joseph P. Burnett ◽  
Ronack B. Shah ◽  
Hayley J. Paholak ◽  
Sean P. McDermott ◽  
Yasuhiro Tsume ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Triple Negative Breast Cancer ◽  
Triple Negative

scholarly journals Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin

2015 ◽  
Vol 151 (2) ◽  
pp. 281-294 ◽  
Author(s):  
Masaya Kai ◽  
Noriko Kanaya ◽  
Shang V. Wu ◽  
Carlos Mendez ◽  
Duc Nguyen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Breast Cancer Stem Cells
Sign in / Sign up

Export Citation Format

Share Document